Search research articles
Contact Us
Filters
Showing results (71-80 of 98) with videos related to
Page
of 10
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 12, 2015
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
Sudarshini Ramanathan, Kristina Prelog, Elizabeth H Barnes, et al.
European Journal of Neurology
|
March 9, 2022
Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome
James D Triplett, Jessica Qiu, Billy O'Brien, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Neurology
|
July 23, 2020
The neuro-otology of Susac syndrome
Todd A Hardy, Rachael L Taylor, Jessica Qiu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Multiple Sclerosis and Related Disorders
|
March 15, 2026
Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortium
Katherine Y Ko, Nabil Seery, Sarah Griffith, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 30, 2024
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease
Ganesha Liyanage, Benjamin P Trewin, Joseph A Lopez, et al.
The Medical Journal of Australia
|
July 31, 2015
A new era in the treatment of multiple sclerosis
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
August 31, 2025
The relationship between patient-reported quality of life and clinician-rated outcome scores in patients with autoimmune encephalitis: a study of the Australian Autoimmune Encephalitis Consortium
Christina Kazzi, Nabil Seery, Sarah Griffith, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 98) with videos related to
Sort By:
Page
of 10
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 12, 2015
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
Sudarshini Ramanathan, Kristina Prelog, Elizabeth H Barnes, et al.
European Journal of Neurology
|
March 9, 2022
Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome
James D Triplett, Jessica Qiu, Billy O'Brien, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Neurology
|
July 23, 2020
The neuro-otology of Susac syndrome
Todd A Hardy, Rachael L Taylor, Jessica Qiu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Multiple Sclerosis and Related Disorders
|
March 15, 2026
Characterising executive functioning in the chronic phase of autoimmune encephalitis: A study by the Australian autoimmune encephalitis consortium
Katherine Y Ko, Nabil Seery, Sarah Griffith, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 30, 2024
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease
Ganesha Liyanage, Benjamin P Trewin, Joseph A Lopez, et al.
The Medical Journal of Australia
|
July 31, 2015
A new era in the treatment of multiple sclerosis
Simon A Broadley, Michael H Barnett, Mike Boggild, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
August 31, 2025
The relationship between patient-reported quality of life and clinician-rated outcome scores in patients with autoimmune encephalitis: a study of the Australian Autoimmune Encephalitis Consortium
Christina Kazzi, Nabil Seery, Sarah Griffith, et al.
Page
of 10